Capstone Asset Management’s Integra LifeSciences IART Stock Holding History

Capstone Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$636K	Sell	11,660 -1,330	-10%	-$63.5K	0.02%	770
2017 Q1	$547K	Sell	12,990 -17,570	-57%	-$751K	0.02%	851
2016 Q4	$655K	Buy	30,560 +9,600	+46%	+$390K	0.02%	770
2016 Q3	$865K	Sell	20,960 -100	-0.5%	-$4.19K	0.02%	643
2016 Q2	$840K	Buy	21,060 +1,740	+9%	+$62.6K	0.03%	645
2016 Q1	$651K	Sell	19,320 -880	-4%	-$27.4K	0.02%	760
2015 Q4	$685K	Buy	20,200 +1,480	+8%	+$46.3K	0.02%	732
2015 Q3	$557K	Sell	18,720 -362	-2%	-$11.3K	0.02%	845
2015 Q2	$525K	Sell	19,082 -9,517	-33%	-$254K	0.02%	940
2015 Q1	$721K	Buy	28,599 +2,202	+8%	+$52.1K	0.02%	843
2014 Q4	$585K	Sell	26,397 -2,422	-8%	-$49.1K	0.02%	938
2014 Q3	$585K	Buy	28,819 +685	+2%	+$13.6K	0.02%	909
2014 Q2	$541K	Buy	28,134 +4,266	+18%	+$79.5K	0.02%	1004
2014 Q1	$449K	Sell	23,868 -489	-2%	-$9.44K	0.01%	1147
2013 Q4	$475K	Sell	24,357 -881	-3%	-$16.2K	0.01%	1167
2013 Q3	$415K	Buy	25,238 +783	+3%	+$12.6K	0.01%	1433
2013 Q2	$366K	Buy	+24,455	New	+$358K	0.01%	1445

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capstone Asset Management's IART Position: Q2 2017 in Review

Capstone Asset Management reduced its Integra LifeSciences (IART) stake by 10% in Q2 2017, selling an estimated $63.5K and leaving 11,660 shares worth $636K. The position accounts for 0.02% of the portfolio, ranked #770.

Capstone Asset Management first reported a position in IART in Q2 2013 and has held it in 17 quarters since. The position peaked at $865K in Q3 2016. 223 funds tracked by Wall St. Rank hold IART as of Q2 2017.

Capstone Asset Management held 11,660 shares of Integra LifeSciences worth $636K as of Q2 2017.
Capstone Asset Management sold 1,330 Integra LifeSciences shares in Q2 2017, an estimated $63.5K.
Integra LifeSciences made up 0.02% of Capstone Asset Management's portfolio in Q2 2017, its #770 holding.
Capstone Asset Management first reported a position in Integra LifeSciences in Q2 2013 and has held it in 17 quarters since.
Capstone Asset Management's Integra LifeSciences position peaked at $865K in Q3 2016.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2017.

Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.